Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Positive kidney profile of dogs with Leishmania sp. and treated with miltefosineSemina. Ciências agrárias : revista cultural e científica da Universidade Estadual de Londrina, 2024-03, Vol.44 (2) [Peer Reviewed Journal]ISSN: 1676-546X ;EISSN: 1679-0359 ;DOI: 10.5433/1679-0359.2024v44n2p359Full text available |
|
2 |
Material Type: Article
|
EVALUATION OF MILTEFOSINE AGAINST LEISHMANIA MAJOR (MRHO/IR/75/ER): IN VITRO AND IN VIVO STUDIESActa medica Iranica, 2008-06, Vol.46 (3), p.191-196 [Peer Reviewed Journal]ISSN: 0044-6025 ;EISSN: 1735-9694Full text available |
|
3 |
Material Type: Article
|
Antileishmanial assessment of isoxazole derivatives against L. donovaniRSC medicinal chemistry, 2020-09, Vol.11 (9), p.1053-1062 [Peer Reviewed Journal]This journal is © The Royal Society of Chemistry 2020. ;ISSN: 2632-8682 ;EISSN: 2632-8682 ;DOI: 10.1039/d0md00083c ;PMID: 33479698Full text available |
|
4 |
Material Type: Article
|
Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous LeishmaniasisClinical infectious diseases, 2021-10, Vol.73 (7), p.e2457-e2562 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1238 ;PMID: 33124666Full text available |
|
5 |
Material Type: Article
|
COMPARISON OF EFFICACY OF MILTEFOSINE VERSUS MEGLUMINE ANTIMONATE IN THE TREATMENT OF CUTANEOUS LEISHMANIASISJournal of Ayub Medical College, Abbottabad, 2022-10, Vol.34 (4), p.849-853ISSN: 1025-9589 ;EISSN: 1819-2718 ;DOI: 10.55519/JAMC-04-11135Full text available |
|
6 |
Material Type: Article
|
The anti‐parasitic drug miltefosine suppresses human eosinophil activation and ameliorates murine allergic inflammation in vivoBritish journal of pharmacology, 2021-03, Vol.178 (5), p.1234-1248 [Peer Reviewed Journal]2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.15368 ;PMID: 33450054Full text available |
|
7 |
Material Type: Article
|
Investigation of in vitro Efficacy of Miltefosine on Chronic Cutaneous LeishmaniasisTürkiye parazitolojii dergisi, 2022-05, Vol.46 (2), p.97-101 [Peer Reviewed Journal]ISSN: 1300-6320 ;EISSN: 2146-3077 ;DOI: 10.4274/tpd.galenos.2022.85856 ;PMID: 35604185Full text available |
|
8 |
Material Type: Article
|
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasisScientific reports, 2020-07, Vol.10 (1), p.1-14, Article 12243 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-69276-5 ;PMID: 32699361Full text available |
|
9 |
Material Type: Article
|
Drug resistance and treatment failure in leishmaniasis: A 21st century challengePLoS neglected tropical diseases, 2017-12, Vol.11 (12), p.e0006052-e0006052 [Peer Reviewed Journal]COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Ponte-Sucre A, Gamarro F, Dujardin J-C, Barrett MP, López-Vélez R, García-Hernández R, et al. (2017) Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis 11(12): e0006052. https://doi.org/10.1371/journal.pntd.0006052 ;2017 Ponte-Sucre et al 2017 Ponte-Sucre et al ;2017 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Ponte-Sucre A, Gamarro F, Dujardin J-C, Barrett MP, López-Vélez R, García-Hernández R, et al. (2017) Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis 11(12): e0006052. https://doi.org/10.1371/journal.pntd.0006052 ;ISSN: 1935-2735 ;ISSN: 1935-2727 ;EISSN: 1935-2735 ;DOI: 10.1371/journal.pntd.0006052 ;PMID: 29240765Full text available |
|
10 |
Material Type: Article
|
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical TrialClinical infectious diseases, 2019-04, Vol.68 (9), p.1530-1538 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. 2018 ;The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 1058-4838 ;ISSN: 1537-6591 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciy747 ;PMID: 30188978Full text available |
|
11 |
Material Type: Article
|
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous LeishmaniasisAntimicrobial agents and chemotherapy, 2017-03, Vol.61 (3) [Peer Reviewed Journal]Copyright © 2017 Castro et al. ;Copyright © 2017 Castro et al. 2017 Castro et al. ;ISSN: 0066-4804 ;ISSN: 1098-6596 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.02198-16 ;PMID: 27956421Full text available |
|
12 |
Material Type: Article
|
Recent advances and new strategies on leishmaniasis treatmentApplied microbiology and biotechnology, 2020-11, Vol.104 (21), p.8965-8977 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;ISSN: 0175-7598 ;EISSN: 1432-0614 ;DOI: 10.1007/s00253-020-10856-w ;PMID: 32875362Full text available |
|
13 |
Material Type: Article
|
Miltefosine Treatment of Cutaneous LeishmaniasisClinical infectious diseases, 2021-10, Vol.73 (7), p.e2463-e2464 [Peer Reviewed Journal]ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1461Full text available |
|
14 |
Material Type: Article
|
Oral miltefosine for refractory Acanthamoeba keratitisAmerican journal of ophthalmology case reports, 2019-12, Vol.16, p.100555, Article 100555 [Peer Reviewed Journal]2019 The Authors ;2019 The Authors. ;2019 The Authors 2019 ;ISSN: 2451-9936 ;EISSN: 2451-9936 ;DOI: 10.1016/j.ajoc.2019.100555 ;PMID: 31650083Full text available |
|
15 |
Material Type: Article
|
Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic reviewResearch in contextThe Lancet regional health. Southeast Asia, 2024-03, Vol.22, p.100317 [Peer Reviewed Journal]EISSN: 2772-3682Full text available |
|
16 |
Material Type: Article
|
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in BrazilClinical infectious diseases, 2021-10, Vol.73 (7), p.e2465-e2469 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1337 ;PMID: 32894278Full text available |
|
17 |
Material Type: Article
|
Effect of Itraconazole-Ezetimibe-Miltefosine Ternary Therapy in Murine Visceral LeishmaniasisAntimicrobial agents and chemotherapy, 2021-04, Vol.65 (5) [Peer Reviewed Journal]Copyright © 2021 American Society for Microbiology. ;Copyright © 2021 American Society for Microbiology. 2021 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.02676-20 ;PMID: 33619058Full text available |
|
18 |
Material Type: Article
|
Analytical Method Development and Validation of Trimethylazanium containing Anti-leishmanial Phospholipid Drug Miltefosine by Liquid Chromatography Quadruple Tandem Mass Spectrometry (LC-ESI-MS/MS) API-2000Research journal of pharmacy and technology, 2022-09, Vol.15 (9), p.4128-4134Copyright A&V Publications Sep 2022 ;ISSN: 0974-3618 ;EISSN: 0974-360X ;EISSN: 0974-306X ;DOI: 10.52711/0974-360X.2022.00693Full text available |
|
19 |
Material Type: Article
|
Potency and Preclinical Evidence of Synergy of Oral Azole Drugs and Miltefosine in an Ex Vivo Model of Leishmania ( Viannia ) panamensis InfectionAntimicrobial agents and chemotherapy, 2022-01, Vol.66 (1), p.e0142521 [Peer Reviewed Journal]Copyright © 2022 American Society for Microbiology. ;Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.01425-21 ;PMID: 34694879Full text available |
|
20 |
Material Type: Article
|
Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus YeastsAntimicrobial agents and chemotherapy, 2018-08, Vol.62 (8) [Peer Reviewed Journal]Copyright © 2018 American Society for Microbiology. ;Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.00312-18 ;PMID: 29844051Full text available |